Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
amlodipine besilate, Quantity: 6.935 mg; olmesartan medoxomil, Quantity: 40 mg
Arrotex Pharmaceuticals Pty Ltd
amlodipine besilate,Olmesartan medoxomil
Tablet
Excipient Ingredients: magnesium stearate; iron oxide yellow; titanium dioxide; silicon dioxide; powdered cellulose; polyvinyl alcohol; microcrystalline cellulose; purified talc; croscarmellose sodium; macrogol 8000
Oral
30
(S4) Prescription Only Medicine
Olmesartan and amlodipine combination tablets are indicated for the treatment of hypertension. Treatment should not be initiated with this fixed-dose combination (see Dosage and administration).
Visual Identification: Cream coloured, round shaped, biconvex, film coated tablets with "APO" engraved on one side and "40 over 5" on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 18 Months; Container Temperature: Store below 30 degrees Celsius
Licence status A
2016-01-12